InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Meyers James R, Directeur. Insider active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 4 disclosures have been recorded. History available since 25 February 2022. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
James R. Meyers is a Director at Sangamo Therapeutics, Inc. He contributes to overseeing the company's activities and making strategic decisions within the board. With significant experience in the biopharmaceutical sector, James provides informed perspectives on the challenges and opportunities the company faces. His commitment to corporate governance is an asset to Sangamo.